Today: 30 April 2026
Browse Category

NASDAQ:MCRS 10 September 2025

Engineered Living Therapeutics: How “Bugs as Drugs” Are Transforming Medicine in 2025

Engineered Living Therapeutics: How “Bugs as Drugs” Are Transforming Medicine in 2025

Regulators approved the first microbiome-based therapies for infection in 2022–2023, including Rebyota and Vowst. Next-generation engineered microbes are now in clinical trials for cancer, metabolic, and immune disorders. Synthetic biology advances enable microbes to sense and respond inside the body. Major biotech firms and pharma are investing, with positive Phase 3 results reported for some live microbe therapies in 2025.
10 September 2025
·

Stock Market Today

  • Thursday 4/30 Insider Buying Report: ZBIO CEO and PDX Manager Make Significant Purchases
    April 30, 2026, 11:54 AM EDT. On Thursday, Zenas Biopharma's CEO Leon O. Moulder Jr. bought 60,000 shares at $17.79 each, investing $1.07 million. Following this, ZBIO shares rose 5.1%, with Moulder Jr. up approximately 7.7% on his latest buy. This follows prior purchases totaling $3.43 million over the past year. Meanwhile, Daniel J. Ivascyn, manager at PIMCO Dynamic Income Strategy Fund (PDX), purchased 28,779 shares on Monday for $592,401 at $20.58 each. PDX shares climbed 0.4% Thursday, with Ivascyn's position showing a 2.3% gain. Insider buying often signals confidence in a stock's potential to generate profits, attracting investor attention.

Latest article

Social Security’s $4 Million Question: Can the S&P 500 Beat a 2033 Benefits Cliff?

Social Security’s $4 Million Question: Can the S&P 500 Beat a 2033 Benefits Cliff?

30 April 2026
A retiree’s claim that Social Security payroll taxes could have grown to $4 million in the S&P 500 has renewed debate over the system’s structure. The Social Security Administration projects its main trust fund will be depleted by 2033, with incoming revenue covering 77% of benefits. The fund invests only in government securities, not stocks. The payroll tax rate is set at 12.4% of earnings up to $184,500 in 2026.
Everspin Technologies Stock Surges After $40 Million Defense MRAM Deal Puts Growth Back in View

Everspin Technologies Stock Surges After $40 Million Defense MRAM Deal Puts Growth Back in View

30 April 2026
FatPipe shares jumped 18% to $2.92 Thursday after the company announced expanded access to its SD-WAN and cybersecurity products through public-sector procurement channels. The move follows a VeloCloud replacement program targeting customers of Arista Networks’ SD-WAN business. Trading volume reached 42.2 million shares. Investors remain cautious over execution and customer concentration risks.
Go toTop